Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting Mitochondria in Alzheimer Disease: Rationale and Perspectives
Chiara Lanzillotta, Fabio Di Domenico, Marzia Perluigi, et al.
CNS Drugs (2019) Vol. 33, Iss. 10, pp. 957-969
Open Access | Times Cited: 62

Showing 26-50 of 62 citing articles:

Mitochondria as a promising target for developing novel agents for treating Alzheimer's disease
E. F. Shevtsova, Andrey V. Maltsev, Darya V. Vinogradova, et al.
Medicinal Research Reviews (2020) Vol. 41, Iss. 2, pp. 803-827
Closed Access | Times Cited: 32
Peripheral Administration of a Cell-Penetrating MOTS-c Analogue Enhances Memory and Attenuates Aβ1–42- or LPS-Induced Memory Impairment through Inhibiting Neuroinflammation
Jinhong Jiang, Xin Chang, YaoYan Nie, et al.
ACS Chemical Neuroscience (2021) Vol. 12, Iss. 9, pp. 1506-1518
Closed Access | Times Cited: 27
Protective effect of andrographolide against STZ induced Alzheimer’s disease in experimental rats: possible neuromodulation and Aβ(1–42) analysis
Royal Patel, Karamjeet Kaur, Shamsher Singh
Inflammopharmacology (2021) Vol. 29, Iss. 4, pp. 1157-1168
Closed Access | Times Cited: 26
Metabolic Features of Brain Function with Relevance to Clinical Features of Alzheimer and Parkinson Diseases
D. Allan Butterfield, Maria Favia, Iolanda Spera, et al.
Molecules (2022) Vol. 27, Iss. 3, pp. 951-951
Open Access | Times Cited: 19
Impact of Diet and Exercise on Mitochondrial Quality and Mitophagy in Alzheimer's disease
Jangampalli Adi Pradeepkiran, Md. Ariful Islam, Ujala Sehar, et al.
Ageing Research Reviews (2025), pp. 102734-102734
Closed Access
Discontinued disease-modifying therapies for Alzheimer’s disease: status and future perspectives
Bruno P. Imbimbo, Madia Lozupone, Mark Watling, et al.
Expert Opinion on Investigational Drugs (2020) Vol. 29, Iss. 9, pp. 919-933
Closed Access | Times Cited: 27
Targeting Infectious Agents as a Therapeutic Strategy in Alzheimer’s Disease
Tamàs Fülöp, Usma Munawara, Anis Larbi, et al.
CNS Drugs (2020) Vol. 34, Iss. 7, pp. 673-695
Open Access | Times Cited: 26
Protective activity of ellagic acid in counteract oxidative stress damage in zebrafish embryonic development
Filomena Mottola, Nunzia Scudiero, Concetta Iovine, et al.
Ecotoxicology and Environmental Safety (2020) Vol. 197, pp. 110642-110642
Closed Access | Times Cited: 25
High-Fat Diet Leads to Reduced Protein O-GlcNAcylation and Mitochondrial Defects Promoting the Development of Alzheimer’s Disease Signatures
Ilaria Zuliani, Chiara Lanzillotta, Antonella Tramutola, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3746-3746
Open Access | Times Cited: 21
MST1, a novel therapeutic target for Alzheimer's disease, regulates mitochondrial homeostasis by mediating mitochondrial DNA transcription and the PI3K-Akt-ROS pathway
Dongqing Cui, Haixia Liu, Lili Cao, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Molecular chirality mediated amyloid formation on phospholipid surfaces
Xue Wang, Cunli Wang, Huiying Chu, et al.
Chemical Science (2020) Vol. 11, Iss. 28, pp. 7369-7378
Open Access | Times Cited: 21
A network pharmacology-based study on key pharmacological pathways and targets of Qi Fu Yin acting on Alzheimer's disease
Qiuyue Xiao, Tianyuan Ye, Xiaolong Wang, et al.
Experimental Gerontology (2021) Vol. 149, pp. 111336-111336
Closed Access | Times Cited: 20
Mitochondrial Disorders in Alzheimer’s Disease
В. С. Сухоруков, Natalia M. Mudzhiri, Anastasia S. Voronkova, et al.
Biochemistry (Moscow) (2021) Vol. 86, Iss. 6, pp. 667-679
Closed Access | Times Cited: 20
Recent trends of natural based therapeutics for mitochondria targeting in Alzheimer’s disease
Ashish Dhiman, Mayank Handa, Munindra Ruwali, et al.
Mitochondrion (2022) Vol. 64, pp. 112-124
Closed Access | Times Cited: 13
Role of Mitochondrial Dysfunction in the Pathology of Amyloid-β
Zhenting Huang, Yan Qian, Yangyang Wang, et al.
Journal of Alzheimer s Disease (2020) Vol. 78, Iss. 2, pp. 505-514
Closed Access | Times Cited: 19
Dynamic Interplay between Copper Toxicity and Mitochondrial Dysfunction in Alzheimer’s Disease
Giusy Tassone, Arian Kola, Daniela Valensin, et al.
Life (2021) Vol. 11, Iss. 5, pp. 386-386
Open Access | Times Cited: 15
Diabetes Mellitus: A Path to Amnesia, Personality, and Behavior Change
Rahnuma Ahmad, Kona Chowdhury, Santosh Kumar, et al.
Biology (2022) Vol. 11, Iss. 3, pp. 382-382
Open Access | Times Cited: 10
Calcium Signaling and Mitochondrial Function in Presenilin 2 Knock-Out Mice: Looking for Any Loss-of-Function Phenotype Related to Alzheimer’s Disease
Alice Rossi, Luisa Galla, Chiara Gomiero, et al.
Cells (2021) Vol. 10, Iss. 2, pp. 204-204
Open Access | Times Cited: 12
Personalized Protein-Protein Interaction Networks Towards Unraveling the Molecular Mechanisms of Alzheimer’s Disease
Betül Ceylan, Elif Düz, Tunahan Çakır
Molecular Neurobiology (2023) Vol. 61, Iss. 4, pp. 2120-2135
Closed Access | Times Cited: 4
Quo vadis PGRMC? Grand-Scale Biology in Human Health and Disease
Michael A. Cahill
Frontiers in Bioscience-Landmark (2022) Vol. 27, Iss. 11, pp. 318-318
Open Access | Times Cited: 7
Minocycline protects against neuronal mitochondrial dysfunction and cognition impairment
Majid Motaghinejad, Manijeh Motevalian, Luis Ulloa, et al.
Acta Neurobiologiae Experimentalis (2023) Vol. 83, Iss. 1, pp. 71-83
Open Access | Times Cited: 4
Protocol Report on the Transcranial Photobiomodulation for Alzheimer’s Disease (TRAP-AD) Study
Dan V. Iosifescu, Xiaotong Song, Maia B. Gersten, et al.
Healthcare (2023) Vol. 11, Iss. 14, pp. 2017-2017
Open Access | Times Cited: 4
Molecular mechanisms of mitochondrial homeostasis regulation in neurons and possible therapeutic approaches for Alzheimer's Disease
Jiale Ren, Beibei Xiang, Lin Xueling, et al.
Heliyon (2024) Vol. 10, Iss. 17, pp. e36470-e36470
Open Access | Times Cited: 1
Mitochondria-targeting by small molecules against Alzheimer's disease: A mechanistic perspective
Chinmay Pal
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1871, Iss. 3, pp. 167617-167617
Closed Access | Times Cited: 1
Energy Crisis Links to Autophagy and Ferroptosis in Alzheimer’s Disease: Current Evidence and Future Avenues
Yonggang Fan, Zhan‐You Wang, Da‐Long He
Current Neuropharmacology (2022) Vol. 21, Iss. 1, pp. 67-86
Open Access | Times Cited: 6

Scroll to top